Dalia Dawoud, PhD, is associate director (research) at the National Institute for Health and Care Excellence (NICE). She has practised as a health economist and researcher for over 20 years. Her current work is focused on advancing HTA and clinical guideline development methods through research. Dalia leads the NICE newly established HTA Innovation Laboratory (HTA Lab) as well as NICE’s portfolio of European Commission funded projects, such as IMI EHDEN and HORIZON 2020 HTx projects. She is widely published in the area of health economics and outcomes research and serves as associate editor of ISPOR journal, Value in Health and as director on the ISPOR Board of Directors (2023-2026).